March Biosciences
PrivateLast Round
Series A
Oct 23, 2024
Total Funding Raised
$50.68M
Momentum Score
50 /100
Company Overview
March Biosciences is a biotechnology company specializing in cell therapy for hematological cancers, utilizing an optimized manufacturing process to produce high-quality CAR T-cells that integrate biological and engineering expertise to enhance patient outcomes in cancer treatment.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
March Biosciences Comps
Public and private peers based on sector, stage, and business model.
March Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Oct 23, 2024 | ||||
| Grant | Sep 1, 2024 | ||||
| Grant | Nov 15, 2023 | ||||
| Series A | Nov 9, 2023 | ||||
| Seed | Jun 26, 2023 |
Key People
Founding team and executive leadership
March Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Cancer Institute | Grant |
| NIH RADx | Grant |
| TMC Venture Fund | Series A |
| 4Bio Capital | Series A |
| CANCER FUND | Series A |
| Texas Medical Center Venture Fund | Seed |
| Cancer Focus Fund | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 24, 2026
Grew 19% QoQ, from 21 to 25 employees.
March Biosciences Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about March Biosciences's valuation, stock price, and market status.
